Status:
WITHDRAWN
Treatment of Ex-vivo Small Bowel Mucosa With a Dedicated Radiofrequency Ablation (SB-RFA) Catheter.
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
Medtronic
Conditions:
Angiodysplasia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Gastrointestinal angiodysplasia (GIAD, a.k.a. angioectasia, arteriovenous malformations or AVM, and vascular ectasia) are mucosal or submucosal dilated blood vessels, usually multifocal, and a frequen...
Detailed Description
Gastrointestinal angiodysplasia (GIAD, a.k.a. angioectasia, arteriovenous malformations or AVM, and vascular ectasia) are mucosal or submucosal dilated blood vessels lined by epithelium with no overly...
Eligibility Criteria
Inclusion
- Understand and provide informed consent.
- All patients must be over 18 years of age, otherwise no age restrictions.
- Healthy small bowel tissue has cleared by pathology as tissue that would otherwise be discarded.
- Patients who are undergoing planned resection of the small bowel will be recruited until the study endpoints are met.
Exclusion
- Inability to provide informed consent.
- Inability to isolate disease free section of small bowel or sufficient small bowel to perform SB-RFA treatment..
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03320395
Start Date
June 1 2017
End Date
December 1 2017
Last Update
October 25 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.